PR Newswire: news distribution, targeting and monitoring
Home Page > News Releases > APAC

Innovative Game Puts Spotlight on Mundipharma's Regional Healthcare Partnership with Manchester City

2017-02-16 11:40
print
rss

SINGAPORE, Feb. 16, 2017 /PRNewswire/ -- Healthcare company Mundipharma has released the Manchester City game, 'BETADINE® Soccer Sprint'. This mobile optimised game will be rolled out in Singapore with the rest of the world to follow.

As BETADINE® is the Official Healthcare Product Partner of Manchester City FC, the Grand Prize is a trip for two to watch Manchester City play at home in Manchester at the Etihad Stadium. The winner will be the individual at the top of the leaderboard on midnight, 31 March 2017. Other weekly prizes include Manchester City merchandise, movie tickets and more.

Mundipharma President, Asia Pacific, Latin America, Middle East, Africa, Raman Singh, said, "We are harnessing the power of technology, enabling us to transform the way we operate so that we continue to deliver better healthcare solutions for patients and doctors."

He added, "Manchester City is an organisation with which we share many similarities, including a focus on innovation, and we're excited to see sport and healthcare coming together in this novel way."

The game will be hosted at http://sg.betadine.com/manchestercity and will not require any download. Players are invited to test their skill and sprint their way to great prizes. There will also be a live leaderboard linked to Facebook where they can track their progress.

http://www.betadine.co/

About Mundipharma

Mundipharma's independent associated companies are privately owned entities covering the world's pharmaceutical markets. Mundipharma is a prime example of a company that consistently delivers high quality products while standing by the values that represent the company. Our mission is to alleviate the suffering of patients with cancer and non-cancer pain and to substantially improve their quality of life. Mundipharma is dedicated to bringing to patients with severe and debilitating diseases the benefit of novel treatment options in fields such as pain, oncology, oncology supportive care, ophthalmology, respiratory disease and consumer healthcare.

For more information please visit: www.mundipharma.com.sg

About BETADINE®

The BETADINE® range of medicines containing Povidone-Iodine is trusted by hospitals around the world for over 60 years to prevent and treat infections. A trusted brand among consumers at home to treat small wounds and grazes, sore throats, feminine infections and to stop minor problems from escalating into big issues. In-vitro studies show that BETADINE® medicines containing Povidone-Iodine kill a broad range of bacteria, viruses and fungi including antibiotic-resistant strains that cause infections. BETADINE® has four main categories of products in Wound Care, Feminine Care, Throat / Oral Care and Infectious Diseases to meet the varying needs of our customers.

®: BETADINE is a registered trademark of Mundipharma

Registered indications differ country to country hence please check with a local Mundipharma office for more information on the local approved prescribing information.

Logo - http://photos.prnasia.com/prnh/20150302/8521501264LOGO

Source: Mundipharma

Featured Video

Electronics Gaming Recent Releases

Computer/Electronics Recent Releases

Entertainment Recent Releases

Health Care/Hospital Recent Releases

Medical/Pharmaceuticals Recent Releases

Mobile Entertainment Recent Releases

Sports Recent Releases

Advanced Search
Search
  
  1. Products & Services
  2. News Releases
  3. Knowledge Center
  4. Journalists & Media
  5. Multimedia Theater
  6. Contact Us